Journal
Nature Communications
Publication Date
11-14-2022
Volume
13
Issue
1
First Page
6929
Document Type
Open Access Publication
DOI
10.1038/s41467-022-34724-5
Rights and Permissions
Sridaran, D., Chouhan, S., Mahajan, K. et al. Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance. Nat Commun 13, 6929 (2022). https://doi.org/10.1038/s41467-022-34724-5 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Sridaran, Dhivya; Chouhan, Surbhi; Mahajan, Kiran; Renganathan, Arun; Weimholt, Cody; Bhagwat, Shambhavi; Reimers, Melissa; Kim, Eric H; Thakur, Manish K; Saeed, Muhammad A; Pachynski, Russell K; Seeliger, Markus A; Miller, W Todd; Feng, Felix Y; and Mahajan, Nupam P, "Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance." Nature Communications. 13, 1. 6929 (2022).
https://digitalcommons.wustl.edu/oa_4/1045
Additional Links
Supplemental material is available for this article at publisher site.
